Free Trial

Cencora (COR) Competitors

Cencora logo
$324.83 +5.43 (+1.70%)
Closing price 10/17/2025 03:59 PM Eastern
Extended Trading
$324.21 -0.62 (-0.19%)
As of 10/17/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, NTRA, LH, and ICLR

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Natera (NTRA), Labcorp (LH), and Icon (ICLR). These companies are all part of the "medical" sector.

Cencora vs. Its Competitors

Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.83% 17.59% 6.36%
Cencora 0.60%267.36%4.31%

In the previous week, Elevance Health had 9 more articles in the media than Cencora. MarketBeat recorded 38 mentions for Elevance Health and 29 mentions for Cencora. Cencora's average media sentiment score of 1.27 beat Elevance Health's score of 0.90 indicating that Cencora is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
25 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cencora
25 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.

Elevance Health currently has a consensus price target of $404.72, indicating a potential upside of 15.99%. Cencora has a consensus price target of $324.91, indicating a potential upside of 0.02%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Cencora.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.52
Cencora
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 10.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.0%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cencora has increased its dividend for 15 consecutive years.

Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$177.01B0.44$5.98B$23.5014.85
Cencora$293.96B0.21$1.51B$9.7233.42

Summary

Cencora beats Elevance Health on 10 of the 19 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$62.95B$8.41B$6.15B$21.84B
Dividend Yield0.68%2.14%5.72%3.62%
P/E Ratio33.4254.5664.3629.73
Price / Sales0.2139.58610.5760.44
Price / Cash16.3321.3137.1024.21
Price / Book80.406.8312.234.59
Net Income$1.51B$247.60M$3.33B$1.02B
7 Day Performance2.14%-0.32%1.17%1.31%
1 Month Performance11.70%-4.55%6.14%-1.47%
1 Year Performance36.81%4.69%59.98%9.54%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.5467 of 5 stars
$324.83
+1.7%
$324.91
+0.0%
+37.9%$62.95B$293.96B33.4246,000Positive News
Analyst Forecast
ELV
Elevance Health
4.7323 of 5 stars
$352.05
+0.4%
$411.06
+16.8%
-21.8%$79.20B$177.01B14.97104,200Upcoming Earnings
Analyst Forecast
MCK
McKesson
4.728 of 5 stars
$739.04
+0.1%
$829.08
+12.2%
+55.0%$91.94B$359.05B29.4745,000Positive News
CAH
Cardinal Health
4.7982 of 5 stars
$155.65
+0.8%
$166.00
+6.6%
+39.6%$36.98B$222.58B24.1357,700Positive News
HSIC
Henry Schein
4.1749 of 5 stars
$65.64
-2.1%
$76.67
+16.8%
-12.1%$7.97B$12.67B21.2125,000Trending News
Analyst Revision
OMI
Owens & Minor
4.8223 of 5 stars
$4.68
-1.8%
$7.63
+63.1%
-65.8%$361.87M$10.70B-0.3023,200
DHR
Danaher
4.9653 of 5 stars
$212.75
-1.0%
$245.91
+15.6%
-23.1%$152.59B$23.88B45.3463,000Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
CVS
CVS Health
4.9334 of 5 stars
$77.39
-0.1%
$78.25
+1.1%
+29.8%$98.11B$386.64B21.61300,000Trending News
Analyst Forecast
Analyst Revision
NTRA
Natera
2.3392 of 5 stars
$169.89
+1.5%
$192.88
+13.5%
+48.5%$23.34B$1.96B-89.044,434News Coverage
Positive News
Analyst Forecast
Short Interest ↑
LH
Labcorp
4.5524 of 5 stars
$276.50
-0.2%
$292.00
+5.6%
+32.7%$22.97B$13.01B30.5170,000News Coverage
Positive News
Analyst Forecast
ICLR
Icon
4.2359 of 5 stars
$192.48
-0.7%
$217.33
+12.9%
-37.3%$15.53B$8.28B19.7841,900News Coverage
Positive News
Upcoming Earnings

Related Companies and Tools


This page (NYSE:COR) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners